Biomarker testing is key in today’s world of personalized medicine. Lung cancer biomarker testing, also known as genetic mutation testing, genomic testing, or next generation sequencing (NGS), looks for the mutations, or “specific biomarkers” in the cells of a tumor. These biomarkers can be used to determine the best course of treatment for a lung cancer patient.
Download 7 Things You Should Know About Biomarker Testing and why it may be beneficial to your treatment.